Marieke N.
- Country
- The Netherlands
- Department
- Anesthesiology
Research Overview
- Phase III Randomized Controlled Trial Evaluating Efficacy and Safety of Capsaicin Cutaneous Patch in Post-Surgical Neuropathic Pain Patients
- A Randomized, Open-Label, Non-Inferiority Trial Comparing Lacosamide and Duloxetine for Chemotherapy-Induced Neuropathic Pain
- MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial
Data & Insights
Has run more than one trial at 1 of 37 partner sites.
Specializations
Neuropathic Pain Management
The investigator specializes in treating chemotherapy-induced polyneuropathy and post-surgical neuropathic pain, exploring innovative therapeutic approaches for pain management.
- Chemotherapy-Related Pain Control
- Post-Surgical Pain Treatment
- Analgesic Therapy Assessment
Current therapeutic interests include evaluating the comparative effectiveness of medications such as lacosamide and duloxetine for neuropathic conditions.
Pain Medicine Applications
The investigator focuses on developing treatment strategies for chronic neuropathic pain conditions, particularly in oncology and post-surgical contexts.
- Topical Pain Treatments
- Comparative Pain Therapies
- Long-term Pain Management
Areas of expertise include the evaluation of targeted pain relief interventions and novel therapeutic applications for persistent neuropathic pain.
Clinical Therapeutics
The investigator works in advancing pain medicine protocols through the assessment of various therapeutic agents and their applications in specific patient populations.
- Treatment Efficacy Analysis
- Pain Control Strategies
- Therapeutic Optimization
Key interests include determining optimal treatment approaches for different types of neuropathic pain conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.